Other languages ScinoPharm Taiwan, Ltd.

Equities

1789

TW0001789006

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
27.85 ^TWD	+0.18%		-1.07%	+5.49%

May. 28	Scinopharm Taiwan, Ltd. Announces Tenure Expiration of the Company's Compensation Committee	CI
May. 28	Scinopharm Taiwan, Ltd. Announces Audit Committee Changes	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Scinopharm Taiwan, Ltd. Announces Tenure Expiration of the Company's Compensation Committee	May. 28
Scinopharm Taiwan, Ltd. Announces Audit Committee Changes	May. 28
Scinopharm Taiwan, Ltd. Elects Lai-Shou Su as Independent Director	May. 28
Scinopharm Taiwan, Ltd. Approves Cash Dividend for 2023	May. 28
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 26
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07
ScinoPharm Taiwan, Ltd. Announces Executive Changes	Nov. 03
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07
Ex-dividend day for final dividend	23-07-05	FA
ScinoPharm Taiwan, Ltd. Announces Compensation Committee Appointments	23-05-29
ScinoPharm Taiwan, Ltd. Announces Independent Director Appointments	23-05-29
ScinoPharm Taiwan, Ltd. Approves Cash Dividend for 2022, Payable on July 28, 2023	23-05-29
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-28
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-08
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-05
ScinoPharm Taiwan : 1H 2022 Web Earnings Conference	22-08-05
ScinoPharm Taiwan : Board of Directors approved to release the Company managers from non-competition restrictions	22-08-05
ScinoPharm Taiwan : Board of Directors approved the company's consolidated financial report of Q2, 2022	22-08-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ScinoPharm Taiwan, Ltd.

Equities

1789

TW0001789006

Other languages

Filters